查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
到 2030 年全球数位生物标记市场预测：按类型、实践、治疗领域、资料收集工具、用途、最终用户和地区进行的全球分析
市场调查报告书
商品编码
1372022

到 2030 年全球数位生物标记市场预测：按类型、实践、治疗领域、资料收集工具、用途、最终用户和地区进行的全球分析

Digital Biomarkers Market Forecasts to 2030 - Global Analysis By Type (Sensors, Mobile Based Applications, Wearable and Other Types), Clinical Practice, Therapeutic Area, Data Collection Tool, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球数位生物标记市场规模将达到 35 亿美元，预计到 2030 年将达到 127 亿美元，预测期内年复合成长率为 20.3%。

数位生物标记是从数位平台和设备收集的公正的、可量化的检测，可提供对人的行为和健康的认识。这些生物标记物可以来自各个地方，包括穿戴式科技、智慧型手机应用程式、感测器和其他数位健康科技。数位生物标记包括各种资料，包括生理、行为和检测资料。

据帕金森氏症基金会称，到2022年，美国每年将有近9万人被诊断出患有帕金森氏症。

医疗保健数位化的进展

医疗领域数位化的进步正在改变医学研究、诊断和治疗的一切。数位生物标记是消费者使用数位健康技术直接收集的有关其健康和疾病管理的资料，以揭示、影响或预测健康领域。它属于。此外，数位生物标记的使用有可能有益于患者的健康，因为它们对于诊断和预后预测变得至关重要。

资料安全问题

资料安全问题也是阻碍全球数位生物标记市场的要素之一。该领域面临的最大问题之一是安全和隐私风险，因为资料的性质使其容易受到骇客攻击和资料窃取。然而，数位治疗产品和服务容易受到外部干扰、讯号损伤和传输损伤。结果，重要的患者资料可能会遗失。因此，数位生物标誌物的全球市场开拓预计将受到此类要素的阻碍。

穿戴式装置的使用增加

随着人们对自己的健康、健身和整体福祉的意识日益增强，尤其是在新冠肺炎 (COVID-19) 疫情之后，穿戴式装置的使用在全球范围内迅速增加。穿戴式健康监测技术有助于追踪佩戴者的健康资讯。此外，随着市场领导者推出先进、易于使用的监测生命征象的可穿戴设备，对数位生物标记的需求也在增长。预计这一趋势将在预测期内持续下去，为市场扩张创造机会。

高资本支出

生物标誌物的发现、开发和检验需要大量的收益支出。然而，进行临床试验并遵守严格的法规标准需要大量资金，这对世界创新能力和小型企业产生负面影响。这些因素阻碍了市场的成长。

COVID-19 的影响

专家们正在寻求数位指标，以促进对受大流行影响的人们进行远端筛检和诊断。此外，许多医疗技术公司正在提供数位生物标记技术来帮助阻止 COVID-19 的爆发。由于这些投资，预计市场将在预测期内扩大。由于 COVID-19 疫情造成的严重困难，政府机构表示有兴趣开发基于数位生物标记的药物。

预计神经系统疾病领域在预测期内将是最大的。

预计神经系统疾病领域在预测期内将是最大的。用于监测、鉴定和管理各种神经系统疾病的数位生物标记的开拓和应用是全球数位生物标记市场中神经系统疾病领域的主要焦点。此外，这些生物标记也用于监测阿兹海默症、帕金森氏症、癫痫和多发性硬化症等疾病的发病和症状。透过持续监测患者的生理和行为资料，医疗保健提供者可以即时了解神经系统疾病，从而实现早期疗育和个人化治疗策略。

预计疼痛管理领域在预测期内复合年复合成长率最高

预计疼痛管理领域在预测期内年复合成长率最高。利用数位健康技术来监测、评估和治疗与慢性疼痛相关的疾病是这部分市场的焦点。此外，透过穿戴式科技、行动应用程式和远端监控系统收集的数位生物标记可以提供有关疼痛程度、持续时间和患者对各种治疗的反应的公正且连续的资讯。这些生物标记提供了更专业、更精确的疼痛管理方法，帮助患者和医疗保健专业人员更好地了解和治疗慢性疼痛。

占比最高的地区

由于人口众多且多样化、医疗保健系统不断扩大以及智慧型手机和穿戴式装置的普及不断提高，亚太地区预计将在预测期内占据最大份额。此外，该地区为采用数位生物标记物提供了重要机会。糖尿病、心臟病和癌症等慢性病在亚洲和太平洋地区很常见。

复合年复合成长率最高的地区

据估计，亚太地区的年复合成长率最高。该地区在医疗保健基础设施和技术方面进行了大量投资，促进了数位医疗解决方案的发展。此外，远端医疗、穿戴式科技以及支持数位健康配合措施的政府和私人公司进一步推动了对数位生物标记物的需求。

提供免费客製化

订阅此报告的客户可以利用以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究来源
    • 主要研究来源
    • 二次研究来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球数位生物标记市场：按类型

  • 感应器
  • 基于行动的应用程式
  • 穿戴式的
  • 其他类型

第6章全球数位生物标记市场：依医疗实践分类

  • 用于预测和预后的数位生物标记物
  • 数位生物标记监测
  • 诊断数位生物标记
  • 其他医疗活动

第7章全球数位生物标记市场：按治疗领域

  • 神经系统疾病
  • 睡眠/运动疾病
  • 精神障碍
  • 呼吸系统疾病
  • 心血管疾病/代谢紊乱
  • 肌肉骨骼疾病
  • 其他治疗领域

第8章全球数位生物标记市场：依资料收集工具分类

  • 资料整合
  • 基于桌面的软体
  • 其他资料收集工具

第9章全球数位生物标记市场：依用途

  • 情绪/行为
  • 疼痛管理
  • 神经退化性疾病
  • 其他用途

第10章全球数位生物标记市场：依最终用户分类

  • 糖尿病
  • 医疗服务提供方
  • 生物製药公司
  • 其他最终用户

第11章全球数位生物标记市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第12章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第13章公司简介

  • Abbott
  • ActiGraph LLC
  • Adherium Limited
  • AliveCor, Inc
  • Alphabet, Inc
  • Altoida Inc.
  • Amgen Inc.
  • Aural Analytic
  • Bayer AG
  • Biogen Inc.
  • Empatica Inc.
  • Evidation Health, Inc
  • Feel Therapeutics
  • Fitbit, Inc
  • GlaxoSmithKline Plc
  • Happify Health
  • Kinsa Inc.
  • Koneksa
  • Medopad Ltd
  • Mindstrong Health
  • Neurotrack Technologies, Inc.
  • Novartis International AG
  • Pfizer Inc
  • Sanofi SA
  • Sonde Health, Inc.
  • Verily Life Sciences
  • Vivo Sense
Product Code: SMRC24078

According to Stratistics MRC, the Global Digital Biomarkers Market is accounted for $3.5 billion in 2023 and is expected to reach $12.7 billion by 2030 growing at a CAGR of 20.3% during the forecast period. Digital biomarkers are unbiased, quantifiable measurements gathered from digital platforms or devices that offer perceptions of a person's behavior or health. These biomarkers come from many different places, including wearable technology, smartphone apps, sensors, and other digital health technologies. A wide range of physiological, behavioral, or biometric data can be included in digital biomarkers.

According to Parkinson's Foundation, in 2022, nearly 90,000 people were reported to have been diagnosed with Parkinson's disease in the U.S. each year.

Market Dynamics:

Driver:

Increasing the digitization of healthcare

Medical research, diagnostics, and therapies have all been transformed by rising levels of digitization in the healthcare sector. Digital biomarkers are data that consumers directly collect about their own health or illness management using digital health technology in order to clarify, affect, and/or anticipate results in the area of their health. Additionally, the use of digital biomarkers can help patients' health because they are becoming more and more essential in diagnoses and prognostics.

Restraint:

Concerns about data security

Data security issues are an additional factor that's hampering the global market for digital biomarkers. One of the biggest issues facing the sector is security and privacy hazards because of the nature of data and its susceptibility to hacker assaults and data theft. However, digital therapeutic products and services are susceptible to external interference, signal faults, and transmission failures. Critical patient data could be lost as a result of this. The development of the global market for digital biomarkers is then anticipated to be hampered by this.

Opportunity:

Increased use of wearables

Wearable device usage is rising rapidly all across the world in conjunction with the rising public awareness of health, fitness, and overall well-being, particularly in the wake of COVID-19. Wearable health monitoring technology aids in tracking the wearer's health information. Additionally, the demand for digital biomarkers has also expanded as a result of the market leaders' introduction of user-friendly, cutting-edge wearables to monitor vital signs. Over the projection period, this tendency is anticipated to continue, creating opportunity for the market expansion.

Threat:

High capital expenditures

The discovery, development, and/or validation of biomarkers require a significant revenue expenditure. However, a significant amount of capital is needed to conduct clinical trials and adhere to strict regulatory standards, which has a negative impact on innovation and the capabilities of small businesses globally. These elements are hindering market growth.

COVID-19 Impact:

Digital indicators that would make it easier to remotely screen and diagnose COVID-19 people impacted by the current pandemic situation are being sought after by medical specialists. Additionally, a number of health technology companies have contributed their digital biomarker technologies to help stop the COVID-19 outbreak. As a result of this investment, the market is expected to expand over the course of the projected period. Due to the severe hardship caused by the COVID-19 outbreak, governmental entities have indicated interest in developing digital biomarker-based medications.

The neurological disorders segment is expected to be the largest during the forecast period

Neurological Disorders segment is expected to be the largest during the forecast period. The development and application of digital biomarkers to monitor, identify, and manage a variety of neurological illnesses is the primary emphasis of the neurological disorders area of the global market for digital biomarkers. Additionally, these biomarkers are used in this section to monitor the development and symptoms of diseases like Alzheimer's, Parkinson's, epilepsy, multiple sclerosis, and more. Healthcare providers can acquire real-time insights into neurological illnesses by continually monitoring patients' physiological and behavioral data, enabling early intervention and individualized treatment strategies.

The pain management segment is expected to have the highest CAGR during the forecast period

Pain Management segment is expected to have the highest CAGR during the forecast period. Utilizing digital health technologies to monitor, evaluate, and treat diseases associated with chronic pain is the focus of this section of the market. Additionally, digital biomarkers, which are gathered through wearable technology, mobile applications, and remote monitoring systems, offer unbiased and ongoing information on pain level, duration, and patient response to various therapies. These biomarkers provide a more specialized and accurate approach to pain management, assisting patients and healthcare professionals in better comprehending and treating chronic pain.

Region with largest share:

Due to its sizable and diverse population, expanding healthcare system, and rising smartphone and wearable device penetration, the Asia-Pacific region is expected to hold the largest share over the forecast period. Moreover, this region offers significant opportunities for the adoption of digital biomarkers. Chronic diseases like diabetes, heart disease, and cancer are becoming more prevalent in the Asia-Pacific area.

Region with highest CAGR:

Asia Pacific region is estimated to witness highest CAGR. The region's numerous healthcare infrastructure and technology investments are fostering the development of digital health solutions. Furthermore, the demand for digital biomarkers is being further increased by governments and private businesses that are supporting telemedicine, wearable technologies, and digital health initiatives.

Key players in the market:

Some of the key players in Digital Biomarkers market include: Orthofix Abbott, ActiGraph LLC, Adherium Limited, AliveCor, Inc, Alphabet, Inc, Altoida Inc., Amgen Inc., Aural Analytic, Bayer AG, Biogen Inc., Empatica Inc., Evidation Health, Inc, Feel Therapeutics , Fitbit, Inc, GlaxoSmithKline Plc, Happify Health, Kinsa Inc., Koneksa , Medopad Ltd, Mindstrong Health, Neurotrack Technologies, Inc., Novartis International AG, Pfizer Inc, Sanofi S.A, Sonde Health, Inc., Verily Life Sciences and Vivo Sense.

Key Developments:

In January 2023, Koneksa announced the launch of a clinical study comparing the treatment effect between at-home mobile Spirometry using digital biomarkers and in-clinic Spirometry in patients with moderate asthma on long-acting beta-agonist (LABA) treatment.

In January 2023, Aculys Pharma, Inc. and Four H, Inc. announced the research collaboration using wearable devices to help individuals with narcolepsy and excessive daytime sleepiness associated with obstructive sleep apnea syndrome (OSAS).

Types Covered:

  • Sensors
  • Mobile Based Applications
  • Wearable
  • Other Types

Clinical Practices Covered:

  • Predictive and Prognostic Digital Biomarkers
  • Monitoring Digital Biomarkers
  • Diagnostic Digital Biomarkers
  • Other Clinical Practices

Therapeutic Areas Covered:

  • Neurological Disorders
  • Sleep & Movement Disease
  • Psychiatric Disorders
  • Respiratory Disorders
  • Cardiovascular and Metabolic Disorders
  • Musculoskeletal Disorders
  • Other Therapeutic Areas

Data Collection Tools Covered:

  • Data Integration
  • Desktop Based Software
  • Other Data Collection Tools

Applications Covered:

  • Mood and Behavior
  • Pain Management
  • Neurodegenerative Disorders
  • Other Applications

End Users Covered:

  • Diabetes
  • Healthcare Providers
  • Biopharmaceutical Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Digital Biomarkers Market, By Type

  • 5.1 Introduction
  • 5.2 Sensors
  • 5.3 Mobile Based Applications
  • 5.4 Wearable
  • 5.5 Other Types

6 Global Digital Biomarkers Market, By Clinical Practice

  • 6.1 Introduction
  • 6.2 Predictive and Prognostic Digital Biomarkers
  • 6.3 Monitoring Digital Biomarkers
  • 6.4 Diagnostic Digital Biomarkers
  • 6.5 Other Clinical Practices

7 Global Digital Biomarkers Market, By Therapeutic Area

  • 7.1 Introduction
  • 7.2 Neurological Disorders
  • 7.3 Sleep & Movement Disease
  • 7.4 Psychiatric Disorders
  • 7.5 Respiratory Disorders
  • 7.6 Cardiovascular and Metabolic Disorders
  • 7.7 Musculoskeletal Disorders
  • 7.8 Other Therapeutic Areas

8 Global Digital Biomarkers Market, By Data Collection Tool

  • 8.1 Introduction
  • 8.2 Data Integration
  • 8.3 Desktop Based Software
  • 8.4 Other Data Collection Tools

9 Global Digital Biomarkers Market, By Application

  • 9.1 Introduction
  • 9.2 Mood and Behavior
  • 9.3 Pain Management
  • 9.4 Neurodegenerative Disorders
  • 9.5 Other Applications

10 Global Digital Biomarkers Market, By End User

  • 10.1 Introduction
  • 10.2 Diabetes
  • 10.3 Healthcare Providers
  • 10.4 Biopharmaceutical Companies
  • 10.5 Other End Users

11 Global Digital Biomarkers Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Abbott
  • 13.2 ActiGraph LLC
  • 13.3 Adherium Limited
  • 13.4 AliveCor, Inc
  • 13.5 Alphabet, Inc
  • 13.6 Altoida Inc.
  • 13.7 Amgen Inc.
  • 13.8 Aural Analytic
  • 13.9 Bayer AG
  • 13.10 Biogen Inc.
  • 13.11 Empatica Inc.
  • 13.12 Evidation Health, Inc
  • 13.13 Feel Therapeutics
  • 13.14 Fitbit, Inc
  • 13.15 GlaxoSmithKline Plc
  • 13.16 Happify Health
  • 13.17 Kinsa Inc.
  • 13.18 Koneksa
  • 13.19 Medopad Ltd
  • 13.20 Mindstrong Health
  • 13.21 Neurotrack Technologies, Inc.
  • 13.22 Novartis International AG
  • 13.23 Pfizer Inc
  • 13.24 Sanofi S.A
  • 13.25 Sonde Health, Inc.
  • 13.26 Verily Life Sciences
  • 13.27 Vivo Sense

List of Tables

  • Table 1 Global Digital Biomarkers Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Digital Biomarkers Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Digital Biomarkers Market Outlook, By Sensors (2021-2030) ($MN)
  • Table 4 Global Digital Biomarkers Market Outlook, By Mobile Based Applications (2021-2030) ($MN)
  • Table 5 Global Digital Biomarkers Market Outlook, By Wearable (2021-2030) ($MN)
  • Table 6 Global Digital Biomarkers Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 7 Global Digital Biomarkers Market Outlook, By Clinical Practice (2021-2030) ($MN)
  • Table 8 Global Digital Biomarkers Market Outlook, By Predictive and Prognostic Digital Biomarkers (2021-2030) ($MN)
  • Table 9 Global Digital Biomarkers Market Outlook, By Monitoring Digital Biomarkers (2021-2030) ($MN)
  • Table 10 Global Digital Biomarkers Market Outlook, By Diagnostic Digital Biomarkers (2021-2030) ($MN)
  • Table 11 Global Digital Biomarkers Market Outlook, By Other Clinical Practices (2021-2030) ($MN)
  • Table 12 Global Digital Biomarkers Market Outlook, By Therapeutic Area (2021-2030) ($MN)
  • Table 13 Global Digital Biomarkers Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 14 Global Digital Biomarkers Market Outlook, By Sleep & Movement Disease (2021-2030) ($MN)
  • Table 15 Global Digital Biomarkers Market Outlook, By Psychiatric Disorders (2021-2030) ($MN)
  • Table 16 Global Digital Biomarkers Market Outlook, By Respiratory Disorders (2021-2030) ($MN)
  • Table 17 Global Digital Biomarkers Market Outlook, By Cardiovascular and Metabolic Disorders (2021-2030) ($MN)
  • Table 18 Global Digital Biomarkers Market Outlook, By Musculoskeletal Disorders (2021-2030) ($MN)
  • Table 19 Global Digital Biomarkers Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
  • Table 20 Global Digital Biomarkers Market Outlook, By Data Collection Tool (2021-2030) ($MN)
  • Table 21 Global Digital Biomarkers Market Outlook, By Data Integration (2021-2030) ($MN)
  • Table 22 Global Digital Biomarkers Market Outlook, By Desktop Based Software (2021-2030) ($MN)
  • Table 23 Global Digital Biomarkers Market Outlook, By Other Data Collection Tools (2021-2030) ($MN)
  • Table 24 Global Digital Biomarkers Market Outlook, By Application (2021-2030) ($MN)
  • Table 25 Global Digital Biomarkers Market Outlook, By Mood and Behavior (2021-2030) ($MN)
  • Table 26 Global Digital Biomarkers Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 27 Global Digital Biomarkers Market Outlook, By Neurodegenerative Disorders (2021-2030) ($MN)
  • Table 28 Global Digital Biomarkers Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 29 Global Digital Biomarkers Market Outlook, By End User (2021-2030) ($MN)
  • Table 30 Global Digital Biomarkers Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 31 Global Digital Biomarkers Market Outlook, By Healthcare Providers (2021-2030) ($MN)
  • Table 32 Global Digital Biomarkers Market Outlook, By Biopharmaceutical Companies (2021-2030) ($MN)
  • Table 33 Global Digital Biomarkers Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.